Bhanu P Venkatesulu Selected Research

(ortho-nitrophenyl)sulfenyl pentagastrin

11/2021

CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bhanu P Venkatesulu Research Topics

Disease

5	Neoplasms (Cancer) 11/2021 - 01/2018
1	Breast Neoplasms (Breast Cancer) 11/2021
1	Triple Negative Breast Neoplasms 11/2021
1	COVID-19 02/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2018
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2018
1	Atherosclerosis 01/2018

Drug/Important Bio-Agent (IBA)

1	(ortho-nitrophenyl)sulfenyl pentagastrinIBA 11/2021
1	GoldIBA 11/2021
1	CXCR4 Receptors (CXCR4 Receptor)IBA 11/2021
1	Protons (Proton)IBA 03/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2019
1	Arginine (L-Arginine)FDA Link 12/2019
1	Amino Acids FDA Link 12/2019
1	ADI PEG20IBA 12/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	CrizotinibIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018

Therapy/Procedure

5	Radiotherapy 11/2021 - 01/2018
3	Therapeutics 03/2020 - 01/2018
1	Proton Therapy 01/2019
1	Immunotherapy 01/2018
1	Ligation 01/2018